technical update, page-34

(baglimit)

Just read your story with CCC. Not good. A sad case of poor management and too much debt.

I do think OBJ has a vastly different management culture and a business model built on sound research over an extended period of time.

OBJ has just completed 12 months of clinical trial with P&G and have also secured the services of a royalties expert. No details have been released in relation to the product/s that the OBJ technology will be applied to, however one could assume it may be more than one in a particular product range.
Also clinical trials have been completed with Coty.
There is a lot in the pipeline and unlike the CCC management, no grandiose statements have been made in relation to the company's activities.
OBJ is cashed up and has been in a joint venture development phase for some years with its clients and now both parties are ready to reap the rewards.

Cheers

Hoofa